Nifty, Sensex jump 0.8% today; pharma, IT lead

India’s benchmarks bounced back on Monday, April 27, snapping a three-session losing streak as investors leaned into pharma and IT and volatility eased even with crude staying uncomfortably high.

The Nifty today closed at 24,092.70, up 194.75 points or 0.81%. The Sensex today ended at 77,303.63, higher by 639.42 points or 0.83%.

The recovery was broad-based. Reports pointing to a possible easing in West Asia tensions helped risk appetite, while stock-specific moves in largecaps did the heavy lifting.

A rebound, but not a clean risk-on day

The market’s tone improved through the session as selling pressure from last week’s crude-led risk-off stretch eased. Importantly, the rebound did not require a big fall in oil. Brent was still elevated in reports, which tells you positioning and oversold conditions mattered as much as macro comfort.

Another tell was volatility. India VIX cooled during the rebound, reflecting reduced near-term fear after last week’s sharp moves. That drop in implied volatility often invites tactical buying, especially in index heavyweights.

Global cues: geopolitics, oil, and Wall Street’s tech bid

Overnight and early Asia trade remained dominated by shifting US-Iran ceasefire headlines and the practical question markets keep asking: what happens to shipping lanes and energy supply.

Asian equities were largely supported, with Japan’s Nikkei at record levels in parts of the session, helped by strong tech momentum. US equities, too, have been leaning on earnings and mega-cap tech strength, with the S&P 500 and Nasdaq recently printing record closes.

The catch for India is that oil has not decisively cooled. With the Strait of Hormuz disruption risk still in play, crude above $100 keeps inflation expectations, bond yields and the rupee in focus.

What moved Dalal Street today

Domestic action was driven by three linked factors.

First, sentiment improved on headlines suggesting potential de-escalation and a possible reopening of shipping routes. Second, the rally was powered by heavyweight performance, particularly in pharma and select largecaps. Third, market breadth was strong, with broader indices outperforming.

Nifty Midcap 100 and Nifty Smallcap 100 were up about 1% plus, indicating the rebound was not just index management.

Sector leaders: pharma and IT take charge

Pharma led from the front, helped by a single headline that was hard for traders to ignore.

Sun Pharma surged after announcing a large overseas acquisition, and the move spilled into broader healthcare and pharma sentiment. IT also staged a sharp rebound after recent underperformance, with the Nifty IT index up over 2% as investors rotated back into rate-sensitive, global-facing names while Wall Street tech remained firm.

Other cyclical pockets such as realty, media and power also participated, underlining that this was a risk-on session within India.

The big corporate story: Sun Pharma buys Organon

Sun Pharmaceutical Industries announced an agreement to acquire US-listed Organon & Co in an all-cash deal valuing it at $11.75 billion, with Organon shareholders to receive $14 per share.

For Indian investors, the immediate market read-through was straightforward: scale and ambition. The narrative being pitched is a stronger presence in women’s health and biosimilars, and a larger US footprint.

The second-order questions will come quickly: integration, leverage and near-term earnings impact. Even bullish broker commentary flagged that the stock could turn range-bound after the initial re-rating, as the street models funding costs and synergy timelines.

The other headline investors cannot ignore: Paytm and the RBI crackdown

While today’s index action was upbeat, fintech risk took a hit.

One 97 Communications (Paytm) fell sharply after the RBI cancelled Paytm Payments Bank’s licence effective April 24, citing persistent compliance failures including KYC, transaction monitoring and governance. The RBI also said it will seek winding-up, while reiterating the bank has sufficient liquidity to repay deposits.

The broader market impact is not about one stock alone. It is a reminder that regulated financial plumbing can change quickly, and valuations for businesses with regulatory dependencies tend to carry a different risk premium.

What it means for investors

The day’s bounce does two things.

It resets market psychology after a rough patch and brings back the idea that dips will be bought, especially when volatility cools and global equities remain resilient.

At the same time, it does not remove the two macro constraints that matter most right now: elevated crude and headline-driven geopolitics. When oil stays high, India’s risk profile changes. It can pressure the rupee, nudge inflation expectations, and keep rate-cut hopes restrained.

So, while the Nifty today reclaimed 24,000-plus, the sustainability of the move will depend on whether oil stops acting like a tax on growth.

Near-term triggers to track

Three near-term drivers deserve attention.

First, global central banks. The Fed is widely expected to hold rates, but investors will parse commentary for how policymakers are thinking about energy-driven inflation.

Second, crude and shipping headlines. Markets have been trading the ceasefire narrative intraday. That is unlikely to stop until there is clarity on shipping access and supply stability.

Third, flows and risk indicators. Recent data points to heavy FII selling in the prior session. If that persists, rallies can turn selective, with DIIs and retail flows doing most of the stabilising.

The setup for the next session

After Monday’s rebound, traders will watch whether Nifty holds above the 24,000 zone and whether leadership stays with pharma and IT or rotates back to financials.

This is also a market where single-stock events are increasingly moving indices - Sun Pharma on one side, Paytm on the other. That mix can keep the tape strong at the index level while stock selection gets harder.

For now, the message from the close is clear: risk appetite returned, but the market’s comfort still has an oil price attached to it.